Low Baseline Lymphocyte Count May Predict Poorer Overall Survival In Patients With Head And Neck Cancer Treated With Radiation Therapy

jikun huang,joseph m kaminski,john campbell,p stanton,a albasheer,b dasher,j howington,jason a stewart,wendy martin,f kong

DOI: https://doi.org/10.1016/j.ijrobp.2014.05.1728

2014-01-01

Abstract:Low total lymphocyte count and lymphocyte to neutrophil ratio have been reported as poor prognostic indicators for multiple cancers at various stages. However, it is unknown whether the baseline complete blood count is associated with overall survival in patients with head and neck malignancies treated with radiation therapy. The objective of this study is to report the correlation that exists between baseline lymphocyte count and overall survival in patients with head and neck cancer treated with radiation based therapy. This is a retrospective analysis of 150 consecutive patients with non-metastatic Stage I-IV head and neck cancer who were treated with radiation therapy from November of 2009 to October of 2013. Pre-treatment complete blood count, demographic, and clinical variables were extracted from medical records and vital status was obtained by using the Social Security Death Index. Variables and outcomes were analyzed. Of the 150 patients reviewed, 104 had baseline complete blood counts (Median age 58, Male 74, Female 30). The median follow-up duration is 17.5 months. We performed 2 sequential analyses of the data. The initial analysis involved the first 82 patients and it was found that higher baseline lymphocyte count was significantly associated with lower mortality (HR: 0.93, p = 0.0443). The subsequent analysis involved 22 additional patients (n = 104). This was consistent with the findings from the initial analysis: i.e. higher baseline total lymphocyte count was associated with increased overall survival (HR 0.57, p = 0.0665). Other variables such as change in lymphocyte count (HR: 6*10-8, p = 0.749), baseline hemoglobin (HR: 0.87, p = 0.355), lymphocyte-to-neutrophil ratio (HR: 0.92, p = 0.306), age, gender, and race were not significantly associated with overall survival. There may be an association between the baseline lymphocyte count and overall survival in patients with head and neck cancers treated with radiation therapy. This result suggests immune function of each patient may be associated with overall survival. A study with larger sample size and longer follow-up is ongoing to validate this finding.